Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Technology
Sort By
Newest First
Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About Us
Nice Insight
That's Nice
Reach Our Team
Contact Us
Advertise
LinkedIn
My Account
Login
Sign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy Policy
Terms And Conditions
(90)
1 / 5
Research Collab
10x Genomics and Cleveland Clinic Collaborate in Diagnostic Applications of Single Cell and Spatial Technologies in Bladder Cancer
10x Genomics
PR-06-26-02
Jun 17, 2026
Cell-Free Synthesis
Cell-Free Biomanufacturing and the Future of Flexible Biologics Production
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-24
Jun 15, 2026
Digital Sampling
Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling
Jiwoon Kim; Neulbit Kim; Hyeonjung Park
Samsung Biologics
PAO-06-26-CL-01
Jun 10, 2026
Self-Healing
Beyond Cleaning: Could Self-Healing Materials Redefine Bioprocess Surfaces?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-09
May 25, 2026
Lab Software
Lab Thread Introduces Unified Lab Software Platform to Streamline Biological Research
Lab Thread
PR-05-26-01
May 8, 2026
On-Demand Mfg
Pharmacy on Demand: Can Medicines Be Manufactured at the Point of Need?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-01
May 4, 2026
Lab Platform
Connecting Your Lab with an Integrated Digital Thread
Ryan Cawood, Ph.D.
Lab Thread
PAO-03-26-CL-05
Apr 27, 2026
Proteomics
RareCyte Expands Clinical-Scale Spatial Proteomics Portfolio with New Orion Systems and Leadership Appointment
RareCyte
PR-04-26-09
Apr 20, 2026
PAT
From Analytical Visibility to Real-Time Control in Biologics Purification
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-10
Apr 15, 2026
Advanced PAT
Deeper Process Visibility: Advanced Monitoring Technologies for Modern Biologics Manufacturing
David Alvaro, Ph.D.
Pharma's Almanac
PAO-04-26-PA-04
Apr 6, 2026
Synthetic Cells
Synthetic Cells: Rewriting the Rules of Biopharma Engineering
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-03-26-PA-14
Mar 24, 2026
Lab Software
Lab Thread Launches Free Version of Unified Lab Software Platform to Accelerate Academic Research
Lab Thread
PR-03-26-01
Mar 16, 2026
Early-Phase Trials
Innovations in Early-Phase Clinical Trials: Pioneering the Future of Medicine
Craig Boyle. M.D.
Trialmed
PAO-02-26-CL-05
Mar 2, 2026
Acquisition
disAMR Acquires AMR Insights to Build the Leading Global Hub for Antimicrobial Resistance (AMR) Innovation
disAMR
PR-02-26-05
Feb 24, 2026
MES
Modern MES Drives High-Throughput, High-Quality CDMO Manufacturing
Katie Farley
MasterControl
PAO-02-26-CL-02
Feb 13, 2026
PAT
Revolutionizing Cell Culture Bioprocesses with Real-Time Glucose Measurement
Giovanni Campolongo
Hamilton Company
PAO-02-26-CL-01
Feb 5, 2026
Breakthroughs
What emerging technologies or scientific breakthroughs do you believe will most reshape biopharma in the next 10 years?
Pharma's Almanac
PAO-02-26-RT-01
Feb 2, 2026
Innovations
Looking back over the last 30 years, what advance has had the greatest impact on the industry — and why?
Pharma's Almanac
PAO-01-26-RT-01
Jan 5, 2026
Public Offering
INOVIO Announces Pricing of $25 Million Public Offering
Inovio Pharmaceuticals, Inc.
PR-11-25-NI-05
Nov 11, 2025
Technology
What do you consider to be the most important new tools or technology platforms currently being developed?
Pharma's Almanac
PAO-10-25-RT-02
Nov 3, 2025
1 / 5